University of Birmingham Health-related quality of life in bladder cancer patients around the time of diagnosis

• Users may freely distribute the URL that is used to identify this publication. • Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. • User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) • Users may not further distribute the material nor use it for the purposes of commercial gain.

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  J. Catto,et al.  Health-related quality of life after treatment for bladder cancer in England , 2018, British Journal of Cancer.

[3]  D. Barocas,et al.  Quality of Life After Radical Cystectomy. , 2018, The Urologic clinics of North America.

[4]  L. Kiemeney,et al.  Dietary patterns and risk of recurrence and progression in non‐muscle‐invasive bladder cancer , 2018, International journal of cancer.

[5]  Byron C. Jaeger,et al.  Impact of bladder cancer on health‐related quality of life , 2018, BJU international.

[6]  M. Babjuk,et al.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.

[7]  M. Moran,et al.  History of Cystoscopy , 2018 .

[8]  G. Săraci,et al.  Health Related Quality of life in bladder cancer. Current approach and future perspectives , 2017, Clujul medical.

[9]  M. O'Brien,et al.  A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic , 2017, European journal of cancer care.

[10]  V. Zadnik,et al.  Health-related Quality of Life Assessed by the EORTC QLQ-C30 Questionnaire in the General Slovenian Population , 2017, Radiology and oncology.

[11]  J. Seigne,et al.  THE BURDEN OF CYSTOSCOPIC BLADDER CANCER SURVEILLANCE – ANXIETY, DISCOMFORT, AND PATIENT PREFERENCES FOR DECISION MAKING: PD06‐06 , 2017, Urology.

[12]  K. Franks,et al.  Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  M. Milowsky,et al.  Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Summary. , 2016, Journal of oncology practice.

[14]  C. Leach,et al.  Gender, race, BMI, and social support in relation to the health-related quality of life of cancer survivors: a report from the American Cancer Society’s Study of Cancer Survivors II (SCS-II) , 2016, Quality of Life Research.

[15]  D. Fitzsimmons,et al.  Quality‐of‐life outcomes following pelvic exenteration for primary rectal cancer , 2015, The British journal of surgery.

[16]  Mary Robinson,et al.  Encyclopedia of Quality of Life and Well-being Research , 2015 .

[17]  N. James,et al.  A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. , 2015, European urology focus.

[18]  G. Lyratzopoulos,et al.  Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers , 2015, British Journal of Cancer.

[19]  Donna Rowen,et al.  Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma , 2015, Health and Quality of Life Outcomes.

[20]  Y. Lotan,et al.  The economics of bladder cancer: costs and considerations of caring for this disease. , 2014, European urology.

[21]  G. Boustead,et al.  Stage, grade and pathological characteristics of bladder cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour Registry , 2014, BJU international.

[22]  K. White,et al.  The effect of cancer stage and treatment modality on quality of life in oropharyngeal cancer , 2014, The Laryngoscope.

[23]  A. Lopes,et al.  The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? , 2014, Gynecologic oncology.

[24]  U. Sambamoorthi,et al.  A population‐based study comparing HRQoL among breast, prostate, and colorectal cancer survivors to propensity score matched controls, by cancer type, and gender , 2013, Psycho-oncology.

[25]  M. Zeegers,et al.  A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years , 2013, BJU international.

[26]  Giedrius Vanagas,et al.  Does quality of life of prostate cancer patients differ by stage and treatment? , 2013, Scandinavian journal of public health.

[27]  A. Hinz,et al.  Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer , 2013, Supportive Care in Cancer.

[28]  P. Fayers,et al.  Comparing higher order models for the EORTC QLQ-C30 , 2011, Quality of Life Research.

[29]  B. Somani,et al.  Quality of Life With Urinary Diversion , 2010 .

[30]  M. Zeegers,et al.  The West Midlands Bladder Cancer Prognosis Programme: rationale and design , 2010, BJU international.

[31]  G. Mowatt,et al.  Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. , 2010, Health technology assessment.

[32]  Yair Lotan,et al.  Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. , 2009, European urology.

[33]  W. Shipley,et al.  Bladder cancer , 2009, The Lancet.

[34]  R. Hays,et al.  Impact of cancer on health-related quality of life of older Americans. , 2009, Journal of the National Cancer Institute.

[35]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. , 2008, European urology.

[36]  J. Haviland,et al.  The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). , 2007, Breast.

[37]  P. Fayers,et al.  Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes , 2007 .

[38]  M. McGurk,et al.  Head and neck cancer: to what extent can psychological factors explain differences between health-related quality of life and individual quality of life? , 2006, The British journal of oral & maxillofacial surgery.

[39]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[40]  Å. Månsson,et al.  Quality of life in patients with bladder cancer. , 2005, Urologic oncology.

[41]  K. Yoshimura,et al.  Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. , 2005, Urology.

[42]  S. Fisher,et al.  Prospective evaluation of quality of life in patients with oral and oropharyngeal cancer: from diagnosis to three months post-treatment. , 2004, Oral oncology.

[43]  C. Pashos,et al.  Quality of life aspects of bladder cancer: A review of the literature , 2003, Quality of Life Research.

[44]  M. King The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.

[45]  J. Ifver,et al.  The Swedish Health-Related Quality of Life Survey (SWED-QUAL) , 1993, Quality of Life Research.

[46]  E. Ağlamiş,et al.  When should quality of life be measured after radical cystectomy? , 2002, European urology.

[47]  P. Fayers Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. , 2001, European journal of cancer.

[48]  A. Hinz,et al.  Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. , 2001, European journal of cancer.

[49]  Y. Brandberg,et al.  Health-related Quality of Life Measured by the EORTC QLQ-C30: Reference Values From a Large Sample of the Swedish Population , 2000 .

[50]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[51]  P. Fayers,et al.  Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  Michael Koller,et al.  EORTC QLQ–C30 Reference Values Manual , 1998 .

[53]  A. Böhle,et al.  The quality of life during intravesical bacillus Calmette-Guerin therapy. , 1996, The Journal of urology.

[54]  J. Ware,et al.  The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. , 1995, Social science & medicine.

[55]  L. Kessler,et al.  Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis , 1995, Medical care.

[56]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[57]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[58]  T. Moum,et al.  Self-assessed health among Norwegian adults. , 1992, Social science & medicine.

[59]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.